Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Quidel

This article was originally published in The Gray Sheet

Executive Summary

Quidel: Receives FDA marketing clearance for a point-of-care strep throat test, a "lateral flow immunoassay containing highly specific and sensitive antibodies that are reactive to the strep bacterium." The test is 98% accurate and capable of performing a diagnosis in five minutes "without instrumentation," Quidel says. It will be sold under the brand names Card Q.S. and Concise Performance Plus...
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005877

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel